Sirolimus Conversion for Patients with Posttransplant Kaposi's Sarcoma
Open Access
- 1 September 2006
- journal article
- research article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 6 (9), 2164-2168
- https://doi.org/10.1111/j.1600-6143.2006.01412.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Sirolimus Therapy after Early Cyclosporine Withdrawal Reduces the Risk for Cancer in Adult Renal TransplantationJournal of the American Society of Nephrology, 2006
- Efficacy of Conversion to Sirolimus in Posttransplantation Kaposi’s SarcomaTransplantation Proceedings, 2005
- Sirolimus for Kaposi's Sarcoma in Renal-Transplant RecipientsNew England Journal of Medicine, 2005
- Kaposi sarcoma herpesvirus–induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcomaNature Genetics, 2004
- Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirusNature Genetics, 2004
- Conversion to sirolimus: a successful treatment for posttransplantation Kaposi???s sarcoma12Transplantation, 2004
- Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the rapamune maintenance regimen study1 2Transplantation, 2003
- Clinical Features and Contribution of Virological Findings to the Management of Kaposi Sarcoma in Organ-Allograft RecipientsArchives of Dermatology, 2000
- OUTCOME OF KIDNEY TRANSPLANT RECIPIENTS WITH PREVIOUS HUMAN HERPESVIRUS-8 INFECTION1Transplantation, 2000
- AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee.Journal of Clinical Oncology, 1997